Proliferative Diabetic Retinopathy
📧 Sign up to get email alerts when something new happens for Proliferative Diabetic Retinopathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: High Dose Eylea for Proliferative Diabetic Retinopathy Outcomes [Phase 4]
A Phase 4 clinical trial is evaluating high-dose aflibercept (Eylea) for outcomes in Proliferative Diabetic Retinopathy. The study is curren…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR [Phase 3]
A Phase 3 trial is recruiting to compare Faricimab plus panretinal photocoagulation against vitrectomy with endolaser for proliferative diab…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Genetic Markers and Proliferative Diabetic Retinopathy [NA]
A clinical trial investigating genetic markers in Proliferative Diabetic Retinopathy has completed. Sponsor: CHU de Reims.
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: New Pattern of Retinal Laser Treatment for PDR [NA]
The entry describes an exploratory trial evaluating a new pattern of retinal laser treatment for proliferative diabetic retinopathy; the stu…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Single Session vs Multiple-Session Panretinal Photocoagulation for Treatment of Proliferative Diabetic Retinopathy [NA]
Clinical trial evaluating single-session versus multiple-session panretinal photocoagulation for proliferative diabetic retinopathy, with re…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: Biological Changes in Fibrovascular Membranes of Patients With Proliferative Diabetic Retinopathy Following Faricimab Injection [NA]
A completed clinical trial update examining biological changes in fibrovascular membranes in Proliferative Diabetic Retinopathy after Farici…
-
CLINICAL_TRIALS trial_result · 2025-03-28Clinical Trial Update: Immediate Postoperative Bevacizumab Administration in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy [NA]
A clinical trial is investigating immediate postoperative bevacizumab administration in patients with proliferative diabetic retinopathy und…
-
CLINICAL_TRIALS trial_result · 2024-10-23Clinical Trial Update: Ultra-Widefield Fluorescein Angiography-Based Targeted Retinal Photocoagulation Versus Conventional Panretinal Photocoagulation in the Preservation of Visual Function and Regression of Proliferative Diabetic Retinopathy [NA]
Completed clinical trial comparing ultra-widefield fluorescein angiography-guided targeted retinal photocoagulation versus conventional panr…
-
CLINICAL_TRIALS trial_result · 2024-09-25Clinical Trial Update: Outcomes of Retinal Re-surgeries in Silicone Oil Filled Eyes
This completed clinical trial reports the outcomes of retinal re-surgeries in silicone oil–filled eyes, focusing on retinal detachment and p…
-
CLINICAL_TRIALS trial_result · 2024-08-20Clinical Trial Update: Study of Efficacy and Safety of Brolucizumab Versus Panretinal Photocoagulation Laser in Patients With Proliferative Diabetic Retinopathy [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of brolucizumab versus panretinal photocoagulation in proliferative diabetic retinopathy …
-
CLINICAL_TRIALS trial_result · 2024-08-20Clinical Trial Update: Discovering Early Biomarkers in Circulating Endothelial Cells for Diabetes Complications by Single Cell RNA Sequencing
A completed study from Aarhus University Hospital investigates early biomarkers in circulating endothelial cells for diabetes complications …
-
CLINICAL_TRIALS research · 2024-08-02Clinical Trial Update: Pre-operative Vabysmo in Patients With Non-clearing Vitreous Hemorrhage Secondary to Proliferative Diabetic Retinopathy [Phase 4]
A Phase 4 clinical trial is currently enrolling by invitation to evaluate the pre-operative use of Vabysmo (faricimab) in patients with non-…
-
CLINICAL_TRIALS trial_result · 2024-07-19Clinical Trial Update: VISUPRIME® Eye Drops [NA]
Clinical trial update noting the completion of a VISUPRIME Eye Drops study sponsored by VISUfarma SpA for several retinal diseases.
-
CLINICAL_TRIALS research · 2024-06-17Clinical Trial Update: Phase 2 Spectra Study to Evaluate the Safety and Efficacy of OPL-0401 in Patients With Diabetic Retinopathy [Phase 2]
Phase 2 clinical trial evaluating the safety and efficacy of OPL-0401 in diabetic retinopathy; the study is active but not recruiting.
-
CLINICAL_TRIALS withdrawal · 2024-06-03Clinical Trial Update: HLA and it Relation With the Development of Proliferative Diabetic Retinopathy in Mexican Population [Phase 3]
A Phase 3 clinical trial investigating HLA and its relation to the development of proliferative diabetic retinopathy in Mexican patients wit…
-
CLINICAL_TRIALS trial_result · 2024-05-30Clinical Trial Update: Intravitreal Bevacizumab for Diabetic Retinopathy [Phase 2, Phase 3]
A Phase 2/3 trial evaluating intravitreal bevacizumab for diabetic retinopathy was terminated, with the study status listed as terminated.
-
CLINICAL_TRIALS withdrawal · 2024-05-30Clinical Trial Update: Changes in Vitreous Temperature During Phacoemulsification [NA]
The clinical trial examining vitreous temperature changes during phacoemulsification for proliferative diabetic retinopathy has been withdra…
-
CLINICAL_TRIALS trial_result · 2024-05-30Clinical Trial Update: Changes in Macular Thickness After Patterns Scan Laser [Phase 4]
A Phase 4 trial evaluating patterns scan laser for diabetic retinopathy reported changes in macular thickness and the study was terminated.
-
CLINICAL_TRIALS withdrawal · 2024-05-30Clinical Trial Update: Intravitreal Bevacizumab vs Photocoagulation for Proliferative Diabetic Retinopathy [Phase 2, Phase 3]
A clinical trial comparing intravitreal bevacizumab with photocoagulation for proliferative diabetic retinopathy has been withdrawn (Phase 2…
-
CLINICAL_TRIALS trial_result · 2024-05-30Clinical Trial Update: Safety and Efficacy of Low-Fluence PRP for PDR [NA]
A clinical trial evaluating the safety and efficacy of low-fluence panretinal photocoagulation for proliferative diabetic retinopathy has be…
-
CLINICAL_TRIALS trial_result · 2024-05-30Clinical Trial Update: Pain Using Reduced Fluence Parameters in Photocoagulation for Diabetic Retinopathy. [Phase 4]
A Phase 4 clinical trial evaluating reduced fluence parameters for photocoagulation in proliferative diabetic retinopathy has been terminate…
-
CLINICAL_TRIALS trial_result · 2024-05-30Clinical Trial Update: Panretinal Photocoagulation for Proliferative Diabetic Retinopathy in a Single Session Using Low Fluence Parameters [NA]
This clinical trial evaluated single-session panretinal photocoagulation with low fluence parameters for proliferative diabetic retinopathy.…
-
CLINICAL_TRIALS trial_result · 2024-05-30Clinical Trial Update: Changes in Electroretinogram and Contrast Sensitivity After PASCAL Treatment [Phase 4]
A Phase 4 trial update on PASCAL laser treatment for diabetic retinopathy, detailing changes in electroretinogram and contrast sensitivity; …
-
CLINICAL_TRIALS trial_result · 2024-05-14Clinical Trial Update: The Preliminary Safety and Efficacy of RRG001 After Vitrectomy in Subjects With Proliferative Diabetic Retinopathy (PDR) [EARLY_Phase 1]
This early-phase trial update reports preliminary safety and potential efficacy signals for RRG001 after vitrectomy in proliferative diabeti…
-
CLINICAL_TRIALS trial_result · 2024-01-30Clinical Trial Update: Intravitreal Ozurdex After Pars Plana Vitrectomy for Proliferative Diabetic Retinopathy [Phase 2]
Phase 2 clinical trial update evaluating intravitreal Ozurdex after pars plana vitrectomy for proliferative diabetic retinopathy has complet…